Main Article Content

Authors

Description of the cases: A series of 6 cases with a probable diagnosis of sporadic CJD, treated in a Peruvian national reference hospital, are presented.


Clinical findings: The relevant clinical signs were rapidly progressive dementia and myoclonus, followed by akinetic mutism and pyramidal signs.


Treatment and results: Of the cases presented, 80% were men, with an average age of presentation of 65 years and a duration from diagnosis to death of 6.5 months. Laboratory tests, images (Brain Resonance), and protein dosage 14.3.3 were performed to support the clinical suspicion. There is no effective treatment for said pathology at the moment.


Clinical Relevance: Creutzfeldt-Jakob disease (CJD) is a progressive, fatal, neurodegenerative disease of low prevalence and incidence. Great clinical suspicion and the exclusion of other etiologies are required. Currently, there is no treatment for this entity, and there is a high probability of death before one year.


 

Stefany Lizet Espinoza Ramón, Hospital Nacional Edgardo Rebagliati Martins

orcid_id14.png https://orcid.org/0009-0004-9027-4896

Diego Canales, Hospital Nacional Edgardo Rebagliati Martins

orcid_id14.png https://orcid.org/0000-0001-6176-7529

Cecilia Calderón, Hospital Nacional Edgardo Rebagliati Martins

orcid_id14.png https://orcid.org/0000-0003-2915-5260

David Díaz, Hospital Nacional Edgardo Rebagliati Martins

orcid_id14.png https://orcid.org/0000-0002-0098-6389

Elliot Barreto-Acevedo, Hospital Nacional Edgardo Rebagliati Martins

orcid_id14.png https://orcid.org/0000-0002-6791-1074

Baldwin KJ, Correll CM. Prion Disease. Seminars in Neurology [Internet]. 2019 Aug 1;39(4):428-39. Available from: https://pubmed.ncbi.nlm.nih.gov/31533183/ https://doi.org/10.1055/s-0039-1687841

Fragoso DC, Gonçalves Filho AL da M, Pacheco FT, et al. Imaging of Creutzfeldt-Jakob Disease: Imaging Patterns and Their Differential Diagnosis. RadioGraphics. 2017 Jan;37(1):234-57. https://doi.org/10.1148/rg.2017160075

Tee BL, Longoria Ibarrola EM, Geschwind MD. Prion Diseases. Neurol Clin. 2018;36(4):865-897. https://doi.org/10.1016/j.ncl.2018.07.005

Wang H, Rhoads D, Appleby B. Human prion diseases. Current opinion in infectious diseases 2019 Jun;32(3):272-276. https://doi.org/10.1097/QCO.0000000000000552

Uttley L, Carroll C, Wong R, Hilton DA, Stevenson M. Creutzfeldt-Jakob disease: a systematic review of global incidence, prevalence, infectivity, and incubation. The Lancet Infectious Diseases [Internet]. 2020 Jan 1;20(1):e2-10. Available from: https://www.ncbi.nlm.nih.gov/pubmed/31876504 https://doi.org/10.1016/S1473-3099(19)30615-2

Centers for Disease Control and Prevention. Occurrence and Transmission [Internet]. CDC. 2019. Available from: https://www.cdc.gov/prions/cjd/occurrence-transmission.html

Zerr I, Hermann P. Diagnostic challenges in rapidly progressive dementia. Expert Review of Neurotherapeutics. 2018 Sep 17;18(10):761-72. https://doi.org/10.1080/14737175.2018.1519397

Figgie MP, Appleby BS. Clinical Use of Improved Diagnostic Testing for Detection of Prion Disease. Viruses. 2021 Apr 28;13(5):789. https://doi.org/10.3390/v13050789

Inga Zerr, M.D. Laboratory Diagnosis of Creutzfeldt-Jakob Disease. N Engl J Med 2022;386:1345-50. DOI: 10.1056/NEJMra2119323 https://doi.org/10.1056/NEJMra2119323

Hermann et al. Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease. Lancet Neurol. 2021 March ; 20(3): 235-246. doi:10.1016/S1474-4422(20)30477-4. https://doi.org/10.1016/S1474-4422(20)30477-4

Zerr I, Kallenberg K, Summers DM et al. Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain 2009; 132: 2659-68. https://doi.org/10.1093/brain/awp191

Renzo Manara et. al. MRI abnormalities in Creutzfeldt-Jakob disease and other rapidly progressive dementia. Journal of Neurology (2024) 271:300-309 https://doi.org/10.1007/s00415-023-11962-1 https://doi.org/10.1007/s00415-023-11962-1

Andrew G.B. Thompson, Simon H. Mead , Review: Fluid biomarkers in the human prion diseases. Ymcne (2018), https://doi.org/10.1016/j.mcn.2018.12.003

Altuna, M.; Ruiz, I.; Zelaya, M.V.; Mendioroz, M. Role of Biomarkers for the Diagnosis of Prion Diseases: A Narrative Review. Medicina 2022, 58, 473. https:// doi.org/10.3390/medicina58040473 https://doi.org/10.3390/medicina58040473

Muayqil T, Gronseth G, Camicioli R. Evidence-based guideline: diagnostic accuracy of CSF 14-3-3 protein in sporadic Creutzfeldt-Jakob disease: report of the guideline development subcommittee of the American Academy of Neurology. Neurology. 2012 ;79(14):1499-506. https://doi.org/10.1212/WNL.0b013e31826d5fc3

Miranda et. al. Systematic review of pharmacological management in Creutzfeldt-Jakob disease: no options so far?. Academia Brasileira de Neurologia 2022. DOI https://doi.org/ 10.1055/s-0042-1755341 https://doi.org/10.1055/s-0042-1755341

Copeland R, Amin S, Donato A. The Management of Newly Diagnosed Probable Creutzfeldt-Jakob Disease In Acute Rehabilitation Setting: A Case Report. Advances in Clinical Medical Research and Healthcare Delivery. 2022; 2(3). doi: 10.53785/2769-2779.1116. https://doi.org/10.53785/2769-2779.1116

Espinoza Ramón, S. L., Canales, D., Calderón, C., Díaz, D., & Barreto-Acevedo, E. (2024). Sporadic Creutzfeldt Jakob disease: Case series in Peru. Colombia Medica, 55(1), e2035821. https://doi.org/10.25100/cm.v55i1.5821 (Original work published March 30, 2024)

Downloads

Download data is not yet available.